Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1477910

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1477910

Urinary Incontinence Treatment Devices Market Size - By Product (Urethral Sling, Catheter, Electrical Stimulation Device, Artificial Urinary Sphincter), Incontinence (Stress, Urge, Mixed), Category (Internal, External), End-use & Forecast, 2024 - 2032

PUBLISHED:
PAGES: 130 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global Urinary Incontinence Treatment Devices Market will grow at 8.6% CAGR during 2024-2032, driven by the growing aging population worldwide, technological advancements in urinary incontinence treatment devices, and rising awareness about urinary incontinence and its treatment options.

With millions affected by urinary incontinence disorders attributed to factors like aging demographics, lifestyle changes, and rising chronic diseases, the demand for advanced treatment solutions is on the rise. As per Medscape Emedicine, urinary incontinence, often overlooked and underreported, becomes more prevalent with age, impacting 38-55% of women over 60 and 50-84% of elderly residents in long-term care facilities. This surge in prevalence, coupled with growing awareness about urinary incontinence and its complications, is fueling the development and adoption of innovative treatment devices.

Technological advancements, including minimally invasive procedures and wearable solutions, are being pursued to address diverse patient needs. Collaborative efforts between healthcare providers, research institutions, and manufacturers are further enhancing treatment efficacy. Supported by favorable reimbursement policies and government initiatives, the urinary incontinence treatment devices market is poised for significant expansion, offering improved quality of life for affected individuals worldwide.

The Urinary Incontinence Treatment Devices Market is classified based on end-user, product type, category, incontinence, and region.

The catheters segment will gain commendable traction over 2024-2032, as catheters play a vital role in managing urinary incontinence by facilitating the emptying of the bladder. With technological advancements, catheters have become more advanced, offering features such as anti-microbial coatings and improved materials for enhanced patient comfort and reduced risk of infection, thereby inducing segment growth.

Clinics from the end-user segment will expand at a noteworthy CAGR through 2032 as clinics offer specialized care and access to a wide range of treatment options for patients suffering from urinary incontinence. The convenience of outpatient procedures and the availability of skilled healthcare professionals in clinics make them a preferred choice for many patients seeking treatment for urinary incontinence.

Asia Pacific Urinary Incontinence Treatment Devices Industry will expand notably by 2032, driven by rapid urbanization, increasing healthcare infrastructure investments, and a growing aging population in countries such as China, India, and Japan. Moreover, rising awareness about urinary incontinence and improving access to healthcare services is expected to further boost product demand in the region.

Product Code: 8190

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of urinary incontinence (UI)
      • 3.2.1.2 Technological advancements in devices and surgical techniques
      • 3.2.1.3 Growing incidence of prostate cancer
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High procedural cost
      • 3.2.2.2 Risks and complications associated with the procedures
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Pricing analysis
  • 3.9 Future market trends
  • 3.10 Reimbursement scenario

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Urethral slings
    • 5.2.1 Male slings
    • 5.2.2 Female/vaginal slings
      • 5.2.2.1 Transobturator slings
      • 5.2.2.2 Tension-free vaginal tape slings
      • 5.2.2.3 Mini-slings
  • 5.3 Urinary catheters
    • 5.3.1 Indwelling catheters
    • 5.3.2 Intermittent catheters
    • 5.3.3 External catheters
  • 5.4 Electrical stimulation devices
  • 5.5 Artificial urinary sphincters
  • 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Incontinence Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Stress
  • 6.3 Urge
  • 6.4 Mixed
  • 6.5 Other incontinence type

Chapter 7 Market Estimates and Forecast, By Category, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Internal incontinence devices
  • 7.3 External incontinence devices

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Becton, Dickinson and Company
  • 10.2 Boston Scientific Corporation
  • 10.3 B Braun Melsungen AG
  • 10.4 Caldera Medical Inc.
  • 10.5 Coloplast A/S
  • 10.6 ConvaTec Group plc
  • 10.7 Hollister Incorporated
  • 10.8 Medtronic plc
  • 10.9 PROMEDON GmbH
  • 10.10 Teleflex Incorporated
  • 10.11 Zephyr Surgical Implants
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!